EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis

Salam Alkindi, Ahmed Al Subhi, Anil Pathare

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06503-x ↗

Kurz gefasst

Leserbrief in der Zeitschrift Annals of Hematology, 2025. Verfasst von Salam Alkindi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University, P. O. Box 35, Muscat, 123, Oman. sskindi@squ.edu.om. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hematologic Agents, Withholding Treatment, Vaso-Occlusive Crises. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD) is an inherited disorder characterized by abnormal mutation leading to formation of sickle red blood cells. The initial step is the formation of polymers and precipitation of Hemoglobin within the cell. voxelotor is a novel anti-polymerization drug approved for treatment of patients with SCD, resulting in improved hemoglobin level. Recently its clinical development was suspended, as concerns were raised regarding its safety and efficacy. We have evaluated 11 patients who were stable, on voxelotor for a mean period of 191 weeks (range, 8-369). We observed that upon its withdrawal, 8 patients (73%) showed a rapid onset of vaso-occlusive crisis, within a median of 4.7 days, precipitating hemolysis, with a significant drop of Hb, raised reticulocytes, bilirubin, and lactic dehydrogenase. Also, one patient (9.1%) developed acute chest syndrome, whereas five (45.5%) patients needed blood transfusions. Our data confirms that rapid withdrawal of voxelotor could precipitate severe SCD-related crisis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellHematologic AgentsWithholding TreatmentVaso-Occlusive CrisesHumansMaleFemaleAdolescentYoung AdultAdultAcute Chest SyndromeBenzaldehydesPyrazinesPyrazoles

Substanzen

voxelotorHematologic AgentsBenzaldehydesPyrazinesPyrazoles

Autor:innen und Institutionen

  • Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University, P. O. Box 35, Muscat, 123, Oman. sskindi@squ.edu.om.
  • Department of Haematology, College of Medicine & Health Sciences, Sultan Qaboos University, P. O. Box 35, Muscat, 123, Oman.
  • Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.

Zitieren

APA

Alkindi, S., Al Subhi, A., & Pathare, A. (2025). Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis. Annals of Hematology. https://doi.org/10.1007/s00277-025-06503-x

Vancouver

Alkindi S, Al Subhi A, Pathare A. Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis. Annals of Hematology. 2025. doi:10.1007/s00277-025-06503-x

BibTeX
@article{Alkindi2025,
  author = {Alkindi, Salam and Al Subhi, Ahmed and Pathare, Anil},
  title = {Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06503-x}
}
Kostenlos starten →